If you read about schizophrenia online, you will mostly encounter the DSM. If you receive care outside the United States — in the UK, most of Europe, Asia, Africa, Latin America, and Australia — your clinician is far more likely to be using the World Health Organization's ICD-11. Both classify schizophrenia. They mostly agree. But the differences matter, especially for international research, immigration, and second opinions across borders.
The DSM-5-TR and ICD-11 define schizophrenia in broadly compatible ways, but they differ in duration thresholds, symptom emphasis, and the way they handle symptom dimensions.
Two manuals, two histories
The DSM-5-TR is published by the American Psychiatric Association and is the dominant system in the US. The ICD-11, published by the World Health Organization in 2022, is the official statistical standard for the rest of the world and the system most US insurers actually code against, even when clinicians think in DSM language.
The two manuals have evolved in close conversation, and the ICD-11 was deliberately designed to be more compatible with the DSM-5 than its predecessor (ICD-10) was. But they remain genuinely different documents, with different aims.
Where they agree
- Both define schizophrenia as a syndrome of psychotic symptoms (delusions, hallucinations, disorganised thinking) plus negative symptoms and functional impairment.
- Both have abandoned the historical subtypes (paranoid, hebephrenic, catatonic, undifferentiated, residual) as primary categories.
- Both require ruling out substance use and medical conditions before diagnosing schizophrenia.
- Both treat schizoaffective disorder as a separate diagnosis.
Where they differ — the duration threshold
The clearest difference is duration. The DSM-5-TR requires six months of continuous signs of disturbance, including at least one month of active-phase symptoms. The ICD-11 requires only one month of characteristic symptoms.
This means a person could meet ICD-11 criteria for schizophrenia after one month of symptoms, while still being diagnosed with schizophreniform disorder under the DSM-5-TR. Five months later, if the symptoms persist, the DSM diagnosis would change to schizophrenia. The ICD-11 has no equivalent intermediate category.
Where they differ — symptom emphasis
The DSM-5-TR's Criterion A lists five symptom groups (delusions, hallucinations, disorganised speech, grossly disorganised or catatonic behaviour, negative symptoms). At least one of the first three must be present.
The ICD-11 reorganises these into seven symptom groups, with explicit attention to positive symptoms, negative symptoms, depressive mood symptoms, manic mood symptoms, psychomotor symptoms, cognitive symptoms, and first-rank symptoms (such as thought insertion, withdrawal, or broadcast). The ICD-11 also requires that at least one symptom be from a "core" group.
Where they differ — symptom dimensions
One of the most interesting innovations in the ICD-11 is its system of symptom specifiers rated on dimensions:
- Positive symptoms (none, mild, moderate, severe)
- Negative symptoms
- Depressive symptoms
- Manic symptoms
- Psychomotor symptoms
- Cognitive symptoms
This makes the diagnosis much more descriptive. Two people with "schizophrenia" can have very different clinical pictures, and the ICD-11 captures that. The DSM-5-TR has a similar dimensional severity scale, but it is rarely used in practice.
Where they differ — categories around schizophrenia
The DSM-5-TR places schizophrenia inside a chapter called Schizophrenia Spectrum and Other Psychotic Disorders, which includes:
- Schizotypal (personality) disorder
- Delusional disorder
- Brief psychotic disorder
- Schizophreniform disorder
- Schizophrenia
- Schizoaffective disorder
- Substance/medication-induced psychotic disorder
- Psychotic disorder due to another medical condition
The ICD-11's chapter, Schizophrenia or Other Primary Psychotic Disorders, is broadly parallel but does not include schizophreniform disorder as a separate entity. Instead, it has a category called Acute and Transient Psychotic Disorder, which captures sudden, brief psychotic episodes that resolve quickly.
Why this matters in practice
- For patients moving between countries: A diagnosis under one system may not translate exactly into the other. A person diagnosed in the UK with schizophrenia at three months would, in the US, likely carry a schizophreniform diagnosis until six months had passed.
- For research: Studies using DSM-5 and ICD-11 inclusion criteria may capture slightly different populations. Reading research carefully, you will see authors specify which system they used.
- For insurance and benefits: US insurers code in ICD-11 (or, in transition, ICD-10-CM) even when clinicians think in DSM. The diagnostic codes themselves are usually compatible.
- For statistics: WHO global statistics on schizophrenia prevalence, burden, and mortality use ICD-11.
What the WHO is trying to do
The ICD-11's revision was guided by a goal of clinical utility — making criteria short, intuitive, and usable in low-resource settings. WHO field studies tested the criteria with thousands of clinicians worldwide. The result is a manual that is more flexible than the DSM-5, less reliant on rigid duration thresholds, and more dimensional in spirit.
Both systems agree on what matters
The deeper truth, after all the comparisons, is that the two manuals identify essentially the same condition. Across DSM-5-TR and ICD-11, the symptoms are recognisable, the trajectory is recognisable, and the treatments are the same. The differences matter for precision, for research, and for cross-border care — but they do not change what schizophrenia is or how it should be treated.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.